Theragenics Corporation Reports Revenue and Earnings for the Second Quarter and First Half of 2012

Published: Aug 09, 2012

BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2012.

Back to news